Issue
Alert me when new journal issues are available via or via
American Brachytherapy Society 2007 Annual Meeting Program pages 63-68 Full Text | Full-Text PDF (56 KB)
Listing of Plenary, Oral and Poster Presentations of the 28th Annual Meeting of the American Brachytherapy Society pages 69-76 Full Text | Full-Text PDF (97 KB)
Partial breast irradiation using multicatheter interstitial brachytherapy for early breast cancer—results of the German-Austrian Phase II study Vratislav Strnad, J. Oliver Ott, Guido Hildebrandt, Richard Poetter, Alexandra Resch, Josef Hammer, Michael Lotter, Rolf Sauer page 77 Full Text | Full-Text PDF (59 KB)
A comparison of overall survival between patients with low- and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy Jay P. Ciezki, Chandana A. Reddy, Patrick A. Kupelian, Eric A. Klein, Clifford Robinson, Nabil Chehade, Kenneth Angermeier, Andrew Altman, James Ulchaker page 77 Full Text | Full-Text PDF (59 KB)
3D image-guided HDR brachytherapy in locally advanced cervix cancer—comparison of intracavitary and interstitial treatment Subrata Saha, Aloke Ghosh Dastidar, Sourav Sau, Suman Mallik, Jakham Jayanti, Avijit Basu pages 77-78 Full Text | Full-Text PDF (75 KB)
Interstitial prostate implant brachytherapy using an automated, 3-D greedy heuristic optimization and I-125 directional sources Vibha Chaswal, Bruce R. Thomadsen, Liyong Lin, Douglass L. Henderson page 78 Full Text | Full-Text PDF (41 KB)
Clinical outcomes of a Phase II, multi-institutional Cesium-131 permanent prostate brachytherapy trial Bradley R. Prestidge, William S. Bice page 78 Full Text | Full-Text PDF (41 KB)
Permanent prostate brachytherapy for high-risk prostate cancer Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Robert Galbreath, Zachariah Allen, Edward Adamovich, Jonathan Lief pages 78-79 Full Text | Full-Text PDF (59 KB)
A comparison of biochemical relapse-free survival in patients with intermediate-risk prostate cancer treated with radical prostatectomy, external beam radiotherapy, or permanent seed implantation Andrew D. Vassil, Erin S. Murphy, Chandana A. Reddy, Andrew Altman, Nabil Chehade, James Ulchaker, Kenneth Angermeier, Eric A. Klein, Jay P. Ciezki page 79 Full Text | Full-Text PDF (44 KB)
Permanent I-125 prostate brachytherapy performed in the community setting: Validation of the benefit of post-implant ct dosimetry and the prostate D90 as a predictor of 5-year bNED outcome David Linstadt, Dwight Stickney, Mark Logsdon, Anthony Pu, Steven J. Workman, Deepak Chabra, Michael Russo, Laurence B. Goldman page 79 Full Text | Full-Text PDF (44 KB)
Prostatic acid phosphatase predicts cancer-specific survival after Palladium-103 brachytherapy for prostate cancer L. Christine Fang, Michael Dattoli, Kent E. Wallner, Lawrence True, Jennifer Cash, Richard Sorace pages 79-80 Full Text | Full-Text PDF (58 KB)
Cesium-131 prostate brachytherapy: An early experience Brian J. Moran, Michelle H. Braccioforte page 80 Full Text | Full-Text PDF (40 KB)
Stereotactic breast brachytherapy applied peripherally using a compression applicator and HDR Ir-192 Mark J. Rivard, Raymond J. Bricault, Christopher S. Melhus, Jessica R. Hiatt, Piran Sioshansi, David E. Wazer page 80 Full Text | Full-Text PDF (40 KB)
Dosimetric comparison of three radiation sources used in balloon-based breast brachytherapy John J. Munro, David C. Medich pages 80-81 Full Text | Full-Text PDF (54 KB)
Accelerated partial breast irradiation therapy with MammoSite™ balloon catheter for early breast cancer: A review of patients treated at a large community hospital Sudha B. Mahalingam page 81 Full Text | Full-Text PDF (38 KB)
A novel hybrid method of breast brachytherapy: The best of both worlds Charles W. Hodge, Rakesh R. Patel, Rupak K. Das page 81 Full Text | Full-Text PDF (38 KB)
Factors affecting seroma formation in patients treated with MammoSite™ Janice K. Tomberlin, Mary B. Brian, Ajay K. Dubey pages 81-82 Full Text | Full-Text PDF (55 KB)
Total eye plaque activity (U) as a prognostic factor of visual outcome of uveal melanoma patients treated with custom-made Nag Iodine-125 eye plaque Moataz N. El-Ghamry, Subir Nag, Mohammed A. Rahman, Robert Chamber, Fred Davidorf page 82 Full Text | Full-Text PDF (41 KB)
Penile brachytherapy: Results for 60 patients Juanita M. Crook, Laval Grimard, Bernd Esche, Gregory Pond page 82 Full Text | Full-Text PDF (41 KB)
Patterns of Care for Brachytherapy in Europe: Results for 2002 and projects for 2007 Ferran Guedea, Jean Jacques Mazeron, Erik Van Limbergen, Gyoergy Kovacs, Montse Ventura, Guy Francois, Yves Gancberg page 83 Full Text | Full-Text PDF (44 KB)
MRI-based brachytherapy treatment planning for cervix cancer Daniel Zwahlen, John Jezioranski, Philip Chan, Young-Bin Cho, Ivan Yeung, Lee Manchul, Wilfred Levin, Anthony Fyles, Michael Milosevic page 83 Full Text | Full-Text PDF (41 KB)
Adjuvant brachytherapy removes the survival disadvantage of local disease extension in FIGO IIIC endometrial cancer: A SEER registry analysis Peter J. Rossi, Ashesh B. Jani, Ira R. Horowitz, Peter A.S. Johnstone pages 83-84 Full Text | Full-Text PDF (53 KB)
CT-based cervix HDR brachytherapy treatment planning: Is CT simulation necessary for each HDR insertion? Melanie T.M. Davidson, David P. D'Souza, J. Alex Hammond, John S. Radwan, Deidre L. Batchelar page 84 Full Text | Full-Text PDF (38 KB)
Dosimetric comparison of IMRT to HDR intracavitary brachytherapy for cervical cancer Michael C. Dobelbower, Sui Shen, Richard Popple, Robert Y. Kim page 84 Full Text | Full-Text PDF (38 KB)
The sigmoid: An organ at risk Beth A. Erickson, Tracy R. Kelly, Jason Rownd pages 84-85 Full Text | Full-Text PDF (55 KB)
The effect of raising bladder volume on dosimetry of organs at risk in high-dose-rate intracavitary and interstitial brachytherapy of cervix cancer Bikramjit Chakrabarti, Sajal Kumar Ghosh, Phalguni Gupta, Suman Ghorai, Suparna Ghosh Ray, Bishan Basu, Kausik Ghosh, Jakham Jayanti page 85 Full Text | Full-Text PDF (43 KB)
Long-term outcome for high-dose-rate brachytherapy boost treatment of prostate cancer Yasmin Hasan, Christina Mitchell, George Wilson, D. Jeffrey Demanes, Altieri A. Gillian, Alvaro A. Martinez page 85 Full Text | Full-Text PDF (43 KB)
Interstitial high-dose-rate (HDR) brachytherapy for early stage prostate cancer: A report of 193 cases Rufus J. Mark, Paul J. Anderson, Thomas R. Neumann, Murali Nair, Scott Akins, Steven Gurley pages 85-86 Full Text | Full-Text PDF (56 KB)
The role of needle trauma to the neurovascular bundle region (NVB) and its impact on potency following high-dose-rate (HDR) brachytherapy Michel I. Ghilezan, J. Vito Antonucci, Gary S. Gustafson, Peter Chen, Michelle Wallace, Kathleen Saputo, Grace Boyea, Chris Flynn, Alvaro A. Martinez page 86 Full Text | Full-Text PDF (39 KB)
Interstitial hyperthermia during HDR brachytherapy monotherapy for treatment of early stage prostate cancer with benign prostate hyperplasia (BPH) Venita L. Williams, Ajmel Puthawala, Thinh P. Phan, Anil Sharma, A.M. Nisar Syed page 86 Full Text | Full-Text PDF (43 KB)
A multicentric Phase II study of high-dose-rate brachytherapy boost in combination with external beam radiotherapy in patients with intermediate-risk carcinoma of the prostate Tee S. Lim, Gerard C. Morton, Andrew Loblaw, Raxa Sankreacha, Eric Vigneault, Colvin Springer, Liying Zhang page 87 Full Text | Full-Text PDF (42 KB)
HDR brachytherapy and the ureterovesical junction—Is ignorance a good policy or double trouble? Annie Ho, Joseph Bucci, David J. Malouf page 87 Full Text | Full-Text PDF (43 KB)
The effect of the time interval between brachytherapy and postimplant dosimetric evaluation on dosimetric quality: Analysis of the Pro-Qura database Peter D. Grimm, Gregory S. Merrick, John C. Blasko, John E. Sylvester, Zachariah Allen, Wayne M. Butler, Usman-ul-Haq Chaudhry, Michael Sitter page 87 Full Text | Full-Text PDF (42 KB)
Dosimetric comparison of loose seeds and stranded seeds in I-125 permanent implant for low-risk prostate cancer Elantholi P. Saibishkumar, Ivan Yeung, Akbar Beiki-Ardakani, Jette Borg, Cheryl Cummins-Holder, Juanita M. Crook pages 87-88 Full Text | Full-Text PDF (59 KB)
Intraoperative TRUS-fluoroscopy fusion improves prostate brachytherapy quality Peter F. Orio, Ismail Tudor, Sreeram Narayanan, Paul Cho, Yongmin Kim, Gregory S. Merrick, Kent E. Wallner page 88 Full Text | Full-Text PDF (44 KB)
3D-image-based treatment planning for gynecological interstitial brachytherapy (IB) with GEC-ESTRO Working Group recommended dose volume parameters: Initial experience Alexander Chi, Mingcheng Gao, Kevin Albuquerque page 88 Full Text | Full-Text PDF (44 KB)
Cesium-131 permanent prostate brachytherapy: The dosimetric analysis of a multi-institutional Phase II trial William S. Bice, Bradley R. Prestidge pages 88-89 Full Text | Full-Text PDF (56 KB)
Advances in calibration of high-dose-rate brachytherapy sources Larry A. DeWerd, Stephen Davis, Wes Culberson page 89 Full Text | Full-Text PDF (38 KB)
A 3D forward treatment planning algorithm using pre-calculated Monte Carlo data sets for HDR/PDR tandem and ovoid intracavitary systems Michael J. Price, B.S. Firas Mourtada page 89 Full Text | Full-Text PDF (38 KB)
Analysis of interstitial breast brachytherapy plan using dose volume histogram Murali Nair, Rufus J. Mark, Paul J. Anderson, Thomas R. Neumann, Steven Gurley, David White, Joseph Britt Colenda pages 89-90 Full Text | Full-Text PDF (55 KB)
Postoperative urethral dose assessment of I-125 prostate implants using in vivo MOSFET detectors Bradley R. Prestidge, Ines Jurkovic, Amir G. Sadeghi, Leticia Salinas, William S. Bice page 90 Full Text | Full-Text PDF (43 KB)
Long-term urinary function following Iodine-125 prostate brachytherapy Juanita M. Crook, Chris Roberts, Neil Fleshner page 90 Full Text | Full-Text PDF (43 KB)
Long-term urinary and rectal toxicity evaluation after permanent prostate brachytherapy monotherapy Kevin Stephans, Eric A. Klein, Kenneth Angermeier, James Ulchaker, Nabil Chihade, Andrew Altman, Chandana Reddy, Jay P. Ciezki pages 90-91 Full Text | Full-Text PDF (59 KB)
Late urinary symptom flare following prostate brachytherapy: The BCCA experience Stacy Miller, Mira Keyes, Veronika Moravan, Tom Pickles, William J. Morris, Winkle Kwan, Ross Halperin, Mitchell Liu, Howard Pai page 91 Full Text | Full-Text PDF (42 KB)
Acute and late urinary toxicity in 606 prostate brachytherapy patients—The BC Cancer Agency experience Mira Keyes, Stacy Miller, Veronika Mirvan, Howard Pai, Winkle Kwan, Mitchell Liu, William J. Morris, Tom Pickles page 91 Full Text | Full-Text PDF (42 KB)
Influence of segmental urethral dosimetry on urinary morbidity in prostate brachytherapy Carys W. Thomas, Mira Keyes, Mitchell Liu, Veronika Moravan pages 91-92 Full Text | Full-Text PDF (58 KB)
MRSI-directed salvage brachytherapy for locally recurrent adenocarcinoma of the prostate Timothy J. Wallace, Christian E. Shield, Mayer B. Grob, Michael P. Hagan page 92 Full Text | Full-Text PDF (42 KB)
The impact of primary Gleason pattern on survival following brachytherapy for Gleason 7 prostate cancer Gregory S. Merrick, Robert Galbreath, Wayne M. Butler, Kent E. Wallner, Zachariah Allen, Edward Adamovich, Sarah Gutman pages 92-93 Full Text | Full-Text PDF (56 KB)
The impact of urinary storm on late urinary function following permanent prostate brachytherapy Nathan H.J. Bittner, Gregory S. Merrick, Jonathan Lief, Wayne M. Butler, Kent E. Wallner, Zachariah Allen, Robert Galbreath page 93 Full Text | Full-Text PDF (41 KB)
Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy: Implications for brachytherapy treatment planning Gregory S. Merrick, Sarah Gutman, Edward Adamovich, Richard Anderson, Zachariah Allen, Wayne M. Butler, Kent E. Wallner page 93 Full Text | Full-Text PDF (41 KB)
Interstitial high-dose-rate (HDR) brachytherapy+IMRT vs. HDR monotherapy for early stage prostate cancer Rufus J. Mark, Paul J. Anderson, Murali Nair page 93 Full Text | Full-Text PDF (41 KB)
Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants Maxime Villeneuve, Ghyslain Leclerc, Etienne Lessard, Jean Pouliot, Luc Beaulieu page 94 Full Text | Full-Text PDF (43 KB)
Isotope and patient age predict for PSA spikes following permanent prostate brachytherapy Chelsea Bostancic, Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Zachariah Allen, Robert Galbreath, Jonathan Lief, Sarah Gutman page 94 Full Text | Full-Text PDF (40 KB)
Permanent source brachytherapy: A comparison of the effectiveness and safety of two different local anesthetic regimens Donald B. Fuller, Tahir Ijaz page 94 Full Text | Full-Text PDF (40 KB)
The influence of source density on prostate brachytherapy postimplant dosimetry Carys W. Thomas, Alexandra Kruk, Colleen McGahan, Ingrid Spadinger, William J. Morris pages 94-95 Full Text | Full-Text PDF (57 KB)
3D prostate segmentation in TRUS images using image warping and ellipsoid fitting Sara Badiei, Septimiu E. Salcudean, Jim Varah, Nawaid Usmani, Nick Chng, Alexandra Kruk, Ingrid Spadinger, William J. Morris page 95 Full Text | Full-Text PDF (40 KB)
Compatibility of AC electromagnetic localization with brachytherapy seeds and surgical clips Robyn Vera, Peter D. Grimm, Tricia Zeller, Timothy Mate, Richard S. Eidens page 95 Full Text | Full-Text PDF (40 KB)
Penile bulb dosimetry—Does prostate brachytherapy technique matter? Jenny P. Nobes, Sara J. Khaksar, Abdul Ismail, Maria A. Hawkins, Stephen E.M. Langley, Robert W. Laing pages 95-96 Full Text | Full-Text PDF (58 KB)
Design and testing of a custom transurethral ultrasound device with rapid 3D reconstruction using a rotational scanner David R. Holmes, Brian J. Davis, Nicholas J. Hangiandreou, Randall R. Kinnick, Torrence M. Wilson, Lance A. Mynderse, Richard A. Robb page 96 Full Text | Full-Text PDF (44 KB)
Interstitial high-dose-rate (HDR) brachytherapy for early stage breast cancer: A report of 119 cases Rufus J. Mark, Paul J. Anderson, Thomas R. Neumann, Murali Nair, Steven Gurley page 96 Full Text | Full-Text PDF (44 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
